PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsShionogi
Shionogi
Shionogi & Company, Limited (塩野義製薬株式会社, Shionogi Seiyaku Kabushiki Kaisha) is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ).
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
CognexTacrine1993-09-09
Alzheimer disease
DoribaxDoripenem2007-10-12
Bacterial infections
,
Bacterial pneumonia
,
Cross infection
,
Urinary tract infections
,
Ventilator-associated pneumonia
,
Intraabdominal infections
FetcrojaCefiderocol2020-04-232033-2035
Gram-negative bacterial infections
,
Bacterial infections
,
Pyelonephritis
,
Urinary tract infections
FetrojaCefiderocol2019-11-142033-2035
Gram-negative bacterial infections,
Bacterial infections,
Pyelonephritis,
Urinary tract infections
Mulpleo (previously lusutrombopag shionogi)Lusutrombopag2019-02-182024-2031
Thrombocytopenia
MulpletaLusutrombopag2018-07-312024-2031
Thrombocytopenia
RizmoicNaldemedine2019-02-182026-2033
Constipation
RybixTramadol2005-05-052030-2040
Pain
SenshioOspemifene2015-01-142024-2028
Postmenopause,
Atrophy,
Dyspareunia,
Menopause
UrobakSulfamethoxazole1982-01-01
Bacterial infections,
Chlamydiaceae infections,
Chronic bronchitis,
Enterobacteriaceae infections,
Mycoses,
Nocardia infections,
Otitis media,
Pneumocystis pneumonia,
Protozoan infections,
Toxoplasmosis,
Urinary tract infections
UroplusSulfamethoxazole, Trimethoprim1987-09-28
Bacterial infections,
Chlamydiaceae infections,
Chronic bronchitis,
Enterobacteriaceae infections,
Mycoses,
Nocardia infections,
Otitis media,
Pneumocystis pneumonia,
Protozoan infections,
Toxoplasmosis,
Urinary tract infections
Uroplus ssSulfamethoxazole, Trimethoprim1987-09-28
Bacterial infections,
Chlamydiaceae infections,
Chronic bronchitis,
Enterobacteriaceae infections,
Mycoses,
Nocardia infections,
Otitis media,
Pneumocystis pneumonia,
Protozoan infections,
Toxoplasmosis,
Urinary tract infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Cefiderocol
healthy volunteers/patients
,
pharmacokinetics
,
gram-negative bacterial infections
,
intraabdominal infections
,
sepsis
,
urinary tract infections
,
healthcare-associated pneumonia
,
ventilator-associated pneumonia
,
bacterial pneumonia
,
cystic fibrosis
,
bacterial infections
Lusutrombopag
healthy volunteers/patients
,
thrombocytopenic purpura idiopathic
,
thrombocytopenia
Naldemedine
opioid-induced constipation
Ospemifene
atrophy
,
vaginal diseases
Benzocaine
bacterial infections
Calcium carbonate
healthy volunteers/patients
Antithrombin iii
non-small-cell lung carcinoma
,
lung neoplasms
,
infections
,
invasive pulmonary aspergillosis
Olorofim
invasive pulmonary aspergillosis
Etrolizumab
ventilator-associated pneumonia
,
healthcare-associated pneumonia
,
urinary tract infections
,
sepsis
Tenofovir
infections
Alfacalcidol
obesity
Terfenadine
allergic rhinitis seasonal
Sodium chloride
sars-cov-2
Pravafen
hyperlipidemias
Gw810781
hiv infections
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use